FOUNDER and Executive Director for ASX-listed dermatology company Botanix Matt Callahan from the United States will commence an Investor Roadshow in Sydney, Melbourne and Perth.
He will meet with brokers, analysts and members of the press to discuss the company's progress in developing novel treatments for acne, psoriasis, atopic dermatitis and other skin conditions.
Access the Botanix Overview and ASX announcement at asx.com.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 06 Mar 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Mar 19
